Shenzhen Geno-immune Medical Institute

This trial is testing a new gene therapy for children with a rare, life-threatening genetic disorder called ADA-SCID, which destroys the immune system. The goal is to deliver a working copy of the defective gene directly into the patient's bloodstream via a one-time intravenous i…

This trial is testing a one-time gene therapy for babies with a severe, often fatal genetic immune disorder called SCID-X1. Doctors give a single IV infusion containing a corrected gene to try to fix the immune system. The goal is to see if this treatment is safe and can help the…

This trial is testing a new gene therapy for X-linked adrenoleukodystrophy (X-ALD), a severe genetic brain disease that often affects young boys. Researchers are giving patients a one-time treatment that delivers a corrected gene directly into the body, aiming to fix the underlyi…

This study is testing a new type of personalized immunotherapy called CAR-T for patients with aggressive, hard-to-treat brain tumors that have come back after standard treatments. Doctors take a patient's own immune cells, modify them in a lab to recognize a specific protein (DLL…

This trial is testing a new combination of engineered immune cell therapies for people with hard-to-treat B-cell cancers. It aims to improve treatment and prevent cancer from coming back by using cells that target up to seven different markers on cancer cells at once. The study w…

This study is testing a new combination of three immune-based treatments for advanced melanoma that cannot be removed by surgery. It aims to see if using CAR T cells, CTLs, and a special vaccine together is safe and can help control the cancer. The trial will also track how long …

This study is testing a new cell therapy for people with solid tumors that have come back or haven't responded to standard treatments. Doctors take a patient's own immune cells (T cells), genetically modify them in a lab to recognize and attack cancer cells, and then infuse them …

This trial tests a new type of immune cell therapy called 4SCAR-T for people with advanced bladder cancer that has spread and who have run out of standard treatment options. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack cancer cell…

This study is testing a new immunotherapy for advanced ovarian cancer. Doctors take a patient's own immune cells, genetically modify them to better recognize and attack ovarian cancer, then infuse them back into the body. The trial aims to determine if this approach is safe and e…

This study is testing a new type of personalized cell therapy called CAR-T that is engineered to attack melanoma cancer cells using two targets, NG2 and DLL3. It is for adults whose melanoma has come back or stopped responding to standard treatments. The main goals are to see if …

This early-stage study is testing a new treatment for moderate-to-severe COPD, a serious lung disease that makes it hard to breathe. Researchers are giving patients infusions of special stem cells taken from fetal tissue, hoping these cells can repair damaged lung structures and …

This trial is testing a new, fourth-generation version of CAR-T cell therapy for patients whose B-cell cancers have come back or not responded to standard treatments. The therapy involves modifying a patient's own immune cells to better hunt and destroy cancer cells, and includes…